seth rotz
@sethrotz
Pediatric Hematologist/Oncologist/BMT @Cleveland Clinic Children's; opinions my own
ID: 875730816
12-10-2012 14:25:03
1,1K Tweet
661 Followers
420 Following
Congrats 🎉👏 Jaime Baldeón and many thanks 🙏 to @AllAboutB for your outstanding mentorship . We are so proud of our fellowship program Pediatric Hematology/Oncology Stacey Zahler
So proud 👏 Stefanie Thomas, MD giving speech at the graduating class of Paediatric residency Cleveland Clinic Children’s to highlight how amazing this class and the relationship you build with your classmate. Congratulations 🎉
Excited to present data tomorrow European Hematology Association , on behalf of all co-investigators, RUBY Gene therapy trial outcomes using #CRISPR/Cas12a for patients with #Sicklecell eha2024.ehaweb.org/eha/eha2024/en…
Thank you European Hematology Association for selecting our RUBY study Editas Medicine for presentation at gene therapy session. Results from 18 patients showed safety profile consistent with ASCT, Median ANC engrafted 23 days , Plt engrafted 24 days . NO patient had pain episode post infusion
Remember when we used to avoid mismatched unrelated donor transplants for fear of worse GVHD and NRM outcomes? Those days are over. Congrats to the study team!! 🎉CIBMTR NMDP Brian Shaffer Mahasweta Gooptu Javier Bolaños Meade, MD Steve Spellman Antonio Jimenez Jimenez Monzr M. AlMalki, MD #PTCyrules
Entering Year 3 ASTCT NMDP ACCESS Initiative! TY to our partners The Leukemia & Lymphoma Society National Alliance for Caregiving American Cancer Society and supporters Johnson & Johnson Health Equity Sanofi Kite, a Gilead Company Vertex Pharmaceuticals Takeda AstraZeneca bluebird bio BioNTech SE Equity + Access allow = Outcomes
Are you CASTing yet? In a propensity score-matched CIBMTR analysis, CAST was superior to PTCy-Tac-MMF in every aspect with significant p value in terms of relapse and PFS! Shernan Holtan MD Steven Devine Javier Bolaños Meade, MD Mohamad Mohty astctjournal.org/article/S2666-…
"Human Leukocyte Antigen (HLA) Mismatching & Survival in Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies" Journal of Clinical Oncology! 🧵👇